
Manager, Biostatistics
Celldex
Summary
The Manager, Biostatistics will serve as the primary lead study statistician for assigned clinical studies within a designated therapeutic area. This role acts as a bridge between statistical programming teams and clinical development team, taking complete accountability for the statistical integrity, protocol development, analysis, and validation of study deliverables.
Job description
Overview
The Manager, Biostatistics will serve as the primary lead study statistician for assigned clinical studies within a designated therapeutic area. This role acts as a bridge between statistical programming teams and clinical development team, taking complete accountability for the statistical integrity, protocol development, analysis, and validation of study deliverables.
Responsibilities
- Collaborate with clinical development teams to design clinical studies, establish sample sizes, formulate endpoints, and author the statistical sections of clinical trial protocols.
- Develop or review Statistical Analysis Plans (SAPs), design or review data presentation shells (Tables, Figures, and Listings), and oversee the construction of analysis dataset specifications.
- Supervise and review deliverables from external Contract Research Organizations (CROs) to ensure compliance with strict project timelines and quality metrics.
- Draft and perform complex statistical analyses to support Clinical Study Reports (CSRs), investigator brochures, health authority briefing documents, and publications. Assist the cross functional team in responding to ad-hoc regulatory questions.
- Partner with Data Management to define Case Report Forms (CRFs) and guide Statistical Programming teams to ensure analyses aligned with SAP protocols.
- Provide technical leadership, peer-review statistical outputs. Analyze data and interpret results from clinical trials and of data from non-trial sources to facilitate clinical development decision making.
- Preparing presentations and written reports to effectively communicate results to the project team, management, and regulatory agencies.
Qualifications
- A Ph.D. in Statistics, Biostatistics, or a closely related quantitative field with a minimum of 2-4 years of industry experience, OR a Master's degree (M.S.) with 4-6+ years of pharmaceutical/biotech experience.
- Strong hands-on programming experience using SAS and/or R. In-depth familiarity with CDISC data structures (specifically SDTM and ADaM models).
- Deep knowledge of clinical trial design, SAP writing and global clinical trial regulations, including ICH E9 and FDA guidance on statistical principles for clinical trials.
- Proven ability to manage competing project timelines independently, handle vendor friction, and communicate complex statistical concepts to non-statistical team members with appropriate context.
- Excellent written and verbal communication skills.
- Demonstrated ability to work independently and effectively in a fast-paced, resource-conscious biotech environment.
- Ability to manage multiple projects and priorities while maintaining high-quality deliverables.
Requirements
- Ph.D. in Statistics, Biostatistics, or closely related quantitative field with 2-4 years of industry experience, OR Master's degree with 4-6+ years of pharmaceutical/biotech experience
- Strong hands-on programming experience using SAS and/or R
- In-depth familiarity with CDISC data structures (SDTM and ADaM models)
- Deep knowledge of clinical trial design, SAP writing, and global clinical trial regulations including ICH E9 and FDA guidance
- Proven ability to manage competing project timelines independently and handle vendor friction
- Ability to communicate complex statistical concepts to non-statistical team members
- Excellent written and verbal communication skills
- Demonstrated ability to work independently in a fast-paced, resource-conscious biotech environment
- Ability to manage multiple projects and priorities while maintaining high-quality deliverables
Company overview
Celldex Therapeutics is a pioneering biotechnology company focused on developing innovative antibody-based immunotherapies for allergic, inflammatory, and autoimmune disorders. The company leverages its deep expertise in immunology to create novel treatments that engage the human immune system and target critical pathological pathways. Celldex's lead program, barzolvolimab, is a humanized monoclonal antibody inhibitor of KIT, a key receptor tyrosine kinase essential for mast cell function and survival. Mast cells play a central role in many severe inflammatory conditions, and by targeting this core driver, Celldex aims to deliver best-in-class therapeutic options. The company maintains a robust pipeline of proprietary antibody programs supported by in-house capabilities for optimized discovery and development. With a team of 51-200 employees and multiple locations across the United States, Celldex is committed to advancing its clinical programs through rigorous scientific research and development efforts, with the ultimate goal of improving patients' lives through life-changing therapies.